US2019315792A1PendingUtilityA1

Modified fluorinated nucleoside analogues

Assignee: GILEAD PHARMASSET LLCPriority: May 30, 2003Filed: Oct 17, 2018Published: Oct 17, 2019
Est. expiryMay 30, 2023(expired)· nominal 20-yr term from priority
Inventors:Jeremy Clark
A61P 31/16A61P 31/04A61P 43/00A61P 31/00A61P 31/12A61P 31/14A61P 35/00A61P 1/16A61K 31/7068C07H 19/16C07H 19/00C07H 19/04C07H 19/06A61K 31/7072C07H 19/048C07H 19/14
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosed invention provides compositions and methods of treating a Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and a rhinovirus infection in a host, including animals, and especially humans, using a (2′R)-2′-deoxy-2′-fluoro-2′-C-methyl nucleosides, or a pharmaceutically acceptable salt or prodrug thereof.

Claims

exact text as granted — not AI-modified
1 - 129 . (canceled) 
     
     
         130 : A method of synthesizing a compound of formula 1-3: 
       
         
           
           
               
               
           
         
         comprising reacting a compound of formula 1-2: 
       
       
         
           
           
               
               
           
         
         with (diethylamino)sulfur trifluoride, wherein:
 R is lower alkyl, acyl, benzoyl, or mesyl; and 
 Pg is selected from among C(O)-alkyl, C(O)Ph, C(O)aryl, CH 3 , CH 2 -alkyl, CH 2 -alkenyl, CH 2 Ph, CH 2 -aryl, CH 2 O-alkyl, CH 2 O-aryl, SO 2 -alkyl, SO 2 -aryl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or both Pg's may come together to form a 1,3-(1,1,3,3-tetraisopropyl-disiloxanylidene). 
 
       
     
     
         131 : The method of  claim 130 , wherein:
 R is methyl; and   Pg is CH 2 Ph.   
     
     
         132 : A method of synthesizing a compound of formula 2-5: 
       
         
           
           
               
               
           
         
         comprising reacting a compound of formula 2-4: 
       
       
         
           
           
               
               
           
         
         with (diethylamino)sulfur trifluoride, wherein:
 R 4  is NH 2 , NH-acyl, OH, O-acyl, or O-sulfonyl; and 
 PG is selected from among C(O)-alkyl, C(O)Ph, C(O)aryl, CH 3 , CH 2 -alkyl, CH 2 -alkenyl, CH 2 Ph, CH 2 -aryl, CH 2 O-alkyl, CH 2 O-aryl, SO 2 -alkyl, SO 2 -aryl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or both Pg's may come together to form a 1,3-(1,1,3,3-tetraisopropyl-disiloxanylidene). 
 
       
     
     
         133 : The method of  claim 132  wherein:
 R 4  is NHBz; and 
 Pg is C(O)Ph.

Join the waitlist — get patent alerts

Track US2019315792A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.